TIRZ (DRY) 60mg

Tirz GLP-1/GIP (Dry Powder Formulation)
Dual-Action GLP-1/GIP Therapy in a Stable, Compounded Format

Tirz GLP-1/GIP delivers a powerful dual-agonist mechanism in a convenient dry powder form—offering a preservative-free formulation with flexible reconstitution and titration based on clinical needs.

By activating both GLP-1 and GIP receptors, Tirz supports metabolic pathways involved in appetite regulation, glucose control, and insulin sensitivity—making it a versatile tool for protocols targeting weight management and metabolic optimization.

By simultaneously activating both GLP-1 and GIP receptors, Tirz enhances incretin-based pathways known to influence appetite, insulin sensitivity, and energy balance—positioning it as a valuable tool for clinicians exploring next-generation metabolic therapeutics.

Key Features of the Dry Powder Format:

• Dual Incretin Activation: Engages both GLP-1 and GIP receptors to modulate hunger, glucose metabolism, and insulin dynamics
• Precision Titration: Enables customized dosing and escalation protocols based on model response
• Extended Shelf Stability: Lyophilized format preserves potency; reconstitute as needed
• Preservative-Free: Clean compound profile minimizes confounding variables in controlled settings
• Research Efficiency: Practical, cost-conscious solution for experimental and preclinical use

Observed Effects May Include:

• Greater reductions in appetite and body weight compared to GLP-1 alone
• Improvements in glucose tolerance, insulin response, and beta-cell function
• Enhanced satiety and slowed gastric emptying
• Strong safety and tolerability data in GLP-1/GIP combination studies

Format: Dry powder for subcutaneous reconstitution
Source: Compounded by licensed pharmacies for licensed medical professionals.